What problem does the technology solve?
Identify the clinical, operational, or financial task. Establish its current performance, the people accountable for it, and the improvement that would justify a change.
Healthcare & life sciences
Healthcare AI Research & Transformation
Making artificial intelligence work across clinical care, healthcare operations, and life sciences.
The Institute for AI Transformation connects research, technology intelligence, executive perspectives, and strategic advisory to help healthcare leaders decide where AI belongs, what evidence to trust, and how to measure the result.
Our perspective
From technology adoption to measurable performance.
A functioning model, a successful deployment, an improved workflow, and a better healthcare outcome are four different things. Our research and advisory begin with that distinction.
What evidence supports its effectiveness?
Separate a capability described by a vendor from a result observed in practice. Examine study design, deployment conditions, the comparison group, and what the evidence cannot establish.
What does successful adoption require?
Connect data readiness, system integration, clinical involvement, human review, organizational ownership, and cost to an explicit standard for success.
Time saved is not automatically capacity gained. Faster clinical triage is not automatically a demonstrated improvement in patient outcomes. An administrative efficiency is not automatically a reduction in total cost. These are the questions an investment case should resolve.
Examine the supporting researchThe healthcare ecosystem
Different organizations.
Different AI decisions.
We frame research around the environments in which healthcare enterprises operate. The requirements of a hospital, a health plan and a pharmaceutical research team are not interchangeable.
Care delivery
Hospitals & Health Systems
Clinical care, capacity, technology and financial operations must work together. Our focus includes documentation, diagnostic intelligence, operating room utilization, patient flow, care coordination and the conditions required for reliable deployment.
View hospital operationsAmbulatory care
Physician Groups & Care Networks
Examine documentation burden, scheduling, clinical information retrieval and patient access in outpatient settings. Evaluate how an application changes clinician time, staff workload, visit capacity and the economics of a practice.
View clinical documentationCoverage & administration
Health Plans & Payers
Assess claims operations, prior authorization support, utilization management, provider information and member services. The questions include decision accuracy, turnaround time, review quality, transparency and the experience of providers and members.
View payer operationsScientific research
Pharmaceuticals & Biotechnology
Investigate scientific literature, discovery, trial operations, medical information and research knowledge workflows. Distinguish computational performance from reproducible scientific findings and the evidence required for clinical translation.
View life sciences workflowsClinical technology
Medical Devices & Diagnostics
Examine AI in imaging, diagnostic systems, connected devices and medical software. Evaluate performance across patient populations, integration into care pathways, interoperability, monitoring and the limitations of validation data.
View diagnostic intelligenceHealthcare services
Digital Health & Service Organizations
Explore patient navigation, service delivery, scheduling and distributed care operations. Assess whether faster interactions translate into completed tasks, better accessibility, appropriate escalation and a stronger patient experience.
View patient accessThe workflows behind the investment
Where AI belongs.
What leaders should measure.
Eight areas for healthcare AI evaluation. Each starts with a defined task and ends with the evidence an organization needs before it expands adoption.
DocumentationDiagnosticsHospital operationsRevenue cyclePayer operationsPatient accessLife sciencesData & infrastructure
01 / Clinical productivity
Clinical Documentation & Ambient Intelligence
Evaluate applications that prepare draft notes, summarize encounters and retrieve clinical context. The question is not just whether a note can be generated, but how much accurate, accepted work it removes from a clinician's day.
What to measure
Documentation accuracy, omissions, clinician editing time, EHR integration, use by specialty, work outside scheduled hours and changes in visit capacity.
02 / Clinical intelligence
Diagnostic Imaging & Decision Support
Assess detection, prioritization and coordination tools within an actual care pathway. Technical accuracy matters, but so does whether the right clinician receives, trusts and acts on an alert at the right time.
What to measure
False positives and false negatives, response time, missed findings, alert burden, treatment timelines, performance across populations and patient outcomes measured separately from workflow speed.
03 / Capacity & flow
Hospital Operations & Capacity Optimization
Investigate operating room scheduling, patient flow, discharge coordination and resource allocation. A forecast creates value only when teams can change the scheduling or operational decisions it informs.
What to measure
Utilization, avoidable delays, schedule stability, staff workload, patient throughput, length of stay and the cost and effort required to act on a recommendation.
04 / Financial operations
Revenue Cycle & Financial Intelligence
Evaluate documentation integrity, coding assistance, claims preparation, denial review and administrative routing. Separate potential reimbursement opportunities from verified net financial improvement.
What to measure
Coding accuracy, documentation completeness, denial rates, rework, human review, cost per accepted task, implementation expense and realized net revenue impact.
05 / Health plan workflows
Prior Authorization & Payer Operations
Examine tools for gathering clinical information, checking documentation requirements, preparing requests and routing exceptions. Define the boundary between administrative assistance and a consequential coverage decision.
What to measure
Turnaround time, completeness, review accuracy, manual intervention, appeals, escalation quality and the experience of providers and members. Identify who retains decision authority.
06 / Patient services
Patient Access & Engagement
Assess scheduling, navigation, contact center assistance and communication support. An automated interaction is not a successful interaction unless the patient's task is completed or appropriately escalated.
What to measure
Time to access, completed tasks, scheduling errors, escalation accuracy, accessibility, patient experience and cost per resolved interaction rather than cost per message.
07 / Scientific workflows
Drug Discovery & Clinical Research
Evaluate target and molecular research, literature analysis, trial planning, medical information and research knowledge workflows. Match the evaluation to the stage of discovery rather than treating a computational result as a clinical breakthrough.
What to measure
Source traceability, scientific validity, reproducibility, expert review, research productivity and the evidence needed to move from a prediction to experimental or clinical validation.
08 / Enterprise foundations
Healthcare Data & AI Infrastructure
Define how information reaches the application, which systems it can access and who owns its operation. Evaluate data quality and permissions alongside integration, reliability and the ongoing work required to maintain performance.
What to measure
Interoperability, access controls, data completeness, failure recovery, system availability, monitoring effort, human review and total cost across the completed workflow.
Featured research & evidence
Read the findings.
Understand their limits.
Five publications that inform practical healthcare AI decisions. These are external sources, selected and summarized here, not studies conducted by the Institute.
Source transparency
Original publisher, research design, access conditions and the limits of the finding stay attached to each publication.
What makes an AI investment valuable in healthcare?
Source: Driving Adoption of High-Value AI in Healthcare
PHTI examines how evidence, purchasing incentives, payment and care delivery design affect the value of healthcare AI. Its recommendations draw on workshops held in 2025 and 2026 and additional expert interviews.
The executive question: Are we buying a new capability, or changing the conditions that determine whether it improves care, access, and spending?
Interpretation: Expert recommendations, not a representative survey or a measured return from an Institute engagement. Public overview and report download.
Read original publicationWhy healthcare AI pilots struggle to scale
Source: Beyond the Pilot: How CIOs Are Operationalizing AI Across Health Systems in 2026
Research involving more than 60 technology leaders at medium and large US health systems examines AI operationalization, return measurement, EHR dependency, vendor consolidation, and agentic AI.
The executive question: What must change in ownership, integration, and measurement before a successful pilot becomes a sustainable operating capability?
Interpretation: A vendor produced study of a defined respondent group, not a market wide deployment census. Public findings are available; the complete report requires registration with Qventus.
Read original researchThe real productivity impact of AI clinical documentation
Source: Changes in Clinician Time Expenditure and Visit Quantity With Adoption of Artificial Intelligence-Powered Scribes: A Multisite Study
Among 8,581 clinicians across five academic institutions, including 1,809 scribe adopters, adoption was associated with modest reductions in EHR and documentation time and a modest increase in weekly visits. EHR work outside scheduled hours did not change significantly overall.
The executive question: Which clinicians benefit, what work actually disappears, and does time saved translate into capacity or a better working day?
Interpretation: Observational associations, not guaranteed causal effects at every organization. The article explains its methods, adoption patterns and limitations.
Read the original studyThe business case for AI in revenue cycle operations
Source: The Revenue Cycle Intelligence Report
The HFMA Pulse Survey collected responses from 519 CFOs and revenue cycle leaders. Commissioned by AKASA, it examines documentation and coding challenges, generative AI adoption, implementation barriers and differences between organizations of different sizes.
The executive question: Which part of the revenue cycle has a measurable accuracy or productivity problem, and what would establish a net financial benefit?
Interpretation: Reported financial exposure and adoption are respondent estimates, not audited losses or verified recoveries. The public findings summarize a separately gated report.
Read the public findingsFaster workflows are not the same as proven patient benefit
Source: Automated Emergent Large Vessel Occlusion Detection Using Viz.ai Software and Its Impact on Stroke Workflow Metrics and Patient Outcomes in Stroke Centers
A review of 12 studies involving 15,595 patients found shorter stroke treatment workflow times associated with Viz.ai implementation. The pooled analysis did not establish statistically significant improvements in the clinical outcome measures it examined.
The executive question: Does the evidence support better detection, a faster response, or an improved clinical outcome? Those claims require different measures.
Interpretation: A synthesis focused on a named technology, not a verdict on all diagnostic AI. Lack of statistical significance does not prove that a clinical benefit is impossible.
Read the original reviewThis reading list focuses on providers and clinical operations. It does not establish results for payer or life sciences workflows. Sources reviewed October 2026; links lead to the original publishers.